Optison is the 1st contrast agent available in the U.
We have long advocated for broader acceptance and appropriate use of ultrasound contrast agents, which have strong safety profiles and reduce overall health care costs without exposing patients to ionizing radiation. LUMASON is now the first ultrasound contrast agent to obtain FDA approval for use in liver imaging, to improve the sensitivity and specificity of ultrasonography for the differentiation between malignant and benign focal hepatic lesions.
Of course, it is also possible that this is a sign of early miscarriage.
I sincerely hope that’s not the case, but i don’t want to sound like i’m giving false hope.
A., has announced that LUMASON is now approved for use in ultrasonography of the liver for characterization of focal liver lesions in adult and pediatric patients.The team of specialist Consultants, Sonographers, Midwives and Administrative Personnel are dedicated to providing excellence and expertise in the area of pregnancy and gynaecology.